A 72-year-old woman on long-term warfarin therapy for atrial fibrillation presents with spontaneous bruising, epistaxis, and a prolonged prothrombin time (PT 18 seconds, INR 4.2). She has been taking high-dose vitamin E supplements (1200 IU daily) for the past 6 months on the advice of a friend. Her dietary intake of leafy green vegetables has remained unchanged. Which of the following best explains the mechanism of her coagulopathy?

Explanation

## Vitamin E–Warfarin Interaction and Coagulopathy ### Mechanism of Vitamin K-Dependent Clotting Factor Synthesis **Key Point:** Vitamin K is an essential cofactor for γ-carboxylation of glutamic acid residues on clotting factors II, VII, IX, and X. This post-translational modification is required for calcium binding and proper protein folding, enabling these factors to function in the coagulation cascade. ### Role of Vitamin E in Coagulation **High-Yield:** At high doses (>400 IU/day), vitamin E acts as an anticoagulant by: 1. Inhibiting protein kinase C (PKC) 2. Suppressing γ-carboxylase activity (the enzyme responsible for vitamin K-dependent carboxylation) 3. Reducing synthesis of γ-carboxylated (active) clotting factors ### Interaction with Warfarin ```mermaid flowchart TD A[Warfarin + High-dose Vitamin E]:::outcome --> B[Inhibition of Vitamin K Epoxide Reductase]:::action B --> C[Reduced Vitamin K Recycling]:::action A --> D[Suppression of γ-Carboxylase Activity]:::action C --> E[Decreased γ-Carboxylation of Clotting Factors]:::outcome D --> E E --> F[Reduced Synthesis of Factors II, VII, IX, X]:::outcome F --> G[Prolonged PT/INR]:::urgent G --> H[Bleeding Risk]:::urgent ``` ### Clinical Presentation in This Case | Finding | Explanation | |---------|-------------| | Prolonged PT (18 sec, INR 4.2) | Factors II, VII, X are vitamin K-dependent; both warfarin and high-dose vitamin E suppress their synthesis | | Spontaneous bruising & epistaxis | Severe coagulopathy from synergistic inhibition of clotting factor production | | Unchanged dietary vitamin K intake | Rules out reduced vitamin K absorption as the sole cause; the problem is impaired utilization | | 6-month history of vitamin E supplementation | Sufficient time for accumulation of vitamin E and potentiation of warfarin effect | ### Vitamin E Dose–Response Relationship **Clinical Pearl:** - <400 IU/day: minimal anticoagulant effect - 400–1200 IU/day: significant potentiation of warfarin; increased bleeding risk - >1200 IU/day: severe anticoagulant effect; contraindicated in patients on anticoagulants **Warning:** Patients on warfarin should avoid high-dose vitamin E supplements. The interaction is dose-dependent and can lead to life-threatening hemorrhage. ### Mnemonic for Vitamin K-Dependent Factors **"PIVKA"** (Proteins Induced by Vitamin K Absence): - **P**rothrombin (Factor II) - **I**ntermediate complex (Factor VII) - **V**alue (Factor X) - **K**inin (Factor IX) - **A**ntithrombin (not truly vitamin K-dependent, but mnemonic aid) **Tip:** In NEET PG, when a patient on warfarin develops unexplained coagulopathy, always ask about supplements — vitamin E, herbal products (St. John's Wort, ginkgo), and NSAIDs are common culprits.